Procaps Group (Procaps Group) Price-to-Free-Cash-Flow : 7.69 (As of Jun. 18, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Procaps Group Price-to-Free-Cash-Flow?

As of today (2024-06-18), Procaps Group's share price is $2.60. Procaps Group's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 was $0.34. Hence, Procaps Group's Price-to-Free-Cash-Flow Ratio for today is 7.69.

The historical rank and industry rank for Procaps Group's Price-to-Free-Cash-Flow or its related term are showing as below:

PROC' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 6.54 Med: 15.41 Max: 89.59
Current: 7.69

During the past 4 years, Procaps Group's highest Price-to-Free-Cash-Flow Ratio was 89.59. The lowest was 6.54. And the median was 15.41.

PROC's Price-to-Free-Cash-Flow is ranked better than
87.26% of 526 companies
in the Drug Manufacturers industry
Industry Median: 22.605 vs PROC: 7.69

Procaps Group's Free Cash Flow per Share for the three months ended in Sep. 2023 was $0.39. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $0.34.

Procaps Group Price-to-Free-Cash-Flow Historical Data

The historical data trend for Procaps Group's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Procaps Group Price-to-Free-Cash-Flow Chart

Procaps Group Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Price-to-Free-Cash-Flow

75.00

Procaps Group Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Price-to-Free-Cash-Flow	Get a 7-Day Free Trial											-	-	-	-	10.71

Competitive Comparison of Procaps Group's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Procaps Group's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Procaps Group's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Procaps Group's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Procaps Group's Price-to-Free-Cash-Flow falls into.

Procaps Group Price-to-Free-Cash-Flow Calculation

Procaps Group's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio	=	Share Price	/	Free Cash Flow per Share (TTM)
	=	2.60	/	0.338
	=	7.69

Procaps Group's Share Price of today is $2.60.
Procaps Group's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.34.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio

Market Cap

Free Cash Flow

Procaps Group (NAS:PROC) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.

Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.

Procaps Group Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Procaps Group's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Procaps Group (Procaps Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Procaps Group SA (NAS:PROC) » Definitions » Price-to-Free-Cash-Flow

Comparable Companies

Traded in Other Exchanges

9X1:Germany

Address

9 Rue de Bitbourg, Luxembourg, LUX, L-1273

Website

https://www.procapsgroup.com

Procaps Group SA is a developer of pharmaceutical and nutraceutical solutions, medicines, and hospital supplies. It develops, manufactures, and markets over-the-counter (OTC) and prescription drugs, nutritional supplements, and high-potency clinical solutions. The company's segment includes NextGel; Procaps Colombia; CAN; CASAND and Diabetrics. It generates maximum revenue from the Procaps Colombia segment.

Executives

Alexandre Weinstein Manieu	director, 10 percent owner	CHASHAM PLACE, FLAT 1, LONDON X0 SW1X 8HG
Ruben Minski	director, 10 percent owner, officer: Chief Executive Officer	9 RUE DE BITBOURG, C/O PROCAPS GROUP, S.A., LUXEMBOURG N4 L-1273
Jose Minski	director, 10 percent owner	9 RUE DE BITBOURG, C/O PROCAPS GROUP, S.A., LUXEMBOURG N4 L-1273
Sognatore Trust	10 percent owner	OFICINA 503A-02, EDIFICIO QUANTUM, (500) RUTA 8 KM. 17.500 ZONAMERICA, MONTEVIDEO X3 91600
Simphony Trust	10 percent owner	29 BANCROFT MILLS ROAD, WILMINGTON DE 19806
Deseja Trust	10 percent owner	29 BANCROFT MILLS ROAD, WILMINGTON DE 19806
Hoche Partners Pharma Holding S.a.	10 percent owner	3A VAL SAINTE CROIX, LUXEMBOURG N4 L-1371